BeingWell
Published in

BeingWell

Convalescent Plasma Is Hardly A “Breakthrough”

The data for convalescent plasma is not good

Photo by LuAnn Hunt on Unsplash

On August 23, the FDA issued an emergency use authorization for convalescent plasma for the treatment of severe COVID-19. The Trump Administration hailed convalescent plasma as a “breakthrough” treatment for COVID-19. That is a bit of a stretch.

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store